LISSONI ANDREA ALBERTO

Ruolo: 
Ricercatore
Settore scientifico disciplinare: 
GINECOLOGIA E OSTETRICIA (MED/40)

Pubblicazioni

  • Gadducci, A., Cosio, S., Lissoni, A., Zizioli, V., Adorni, M., Ferrero, A., et al. (2020). Impact of Bevacizumab-containing Primary Treatment on Outcome of Recurrent Ovarian Cancer: An Italian Study. ANTICANCER RESEARCH, 40(3), 1543-1550. Dettaglio
  • Colombo, N., Zaccarelli, E., Baldoni, A., Frezzini, S., Scambia, G., Palluzzi, E., et al. (2019). Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer. BRITISH JOURNAL OF CANCER, 121(9), 744-750. Dettaglio
  • de Boer, S., Powell, M., Mileshkin, L., Katsaros, D., Bessette, P., Haie-Meder, C., et al. (2019). Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial. LANCET ONCOLOGY, 20(9), 1273-1285. Dettaglio
  • Gadducci, A., Giuliani, D., Cosio, S., Lissoni, A., Ferrero, A., & Landoni, F. (2019). Clinical outcome of patients with malignant tumors associated with mature cystic teratomas of the ovary: A retrospective multicenter Italian study. ANTICANCER RESEARCH, 39(5), 2513-2517. Dettaglio
  • Ceppi, L., Galli, F., Lamanna, M., Magni, S., Dell'Orto, F., Verri, D., et al. (2019). Ovarian function, fertility, and menopause occurrence after fertility-sparing surgery and chemotherapy for ovarian neoplasms. GYNECOLOGIC ONCOLOGY, 152(2), 346-352. Dettaglio